Armistice Capital’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-118,289
Closed -$8.42M 366
2026
Q1
$8.42M Sell
118,289
-673,711
-85% -$53.1M 0.15% 101
2025
Q4
$65M Sell
792,000
-3,053
-0.4% -$238K 0.77% 17
2025
Q3
$59.7M Buy
795,053
+38,772
+5% +$2.89M 0.89% 14
2025
Q2
$56M Buy
756,281
+453,221
+150% +$31.5M 0.97% 10
2025
Q1
$24.5M Sell
303,060
-91,251
-23% -$7.84M 0.37% 55
2024
Q4
$30.8M Buy
394,311
+205,398
+109% +$17.5M 0.42% 44
2024
Q3
$17.7M Buy
+188,913
New +$15.9M 0.28% 74

Other funds holding GEHC

Armistice Capital's GEHC Position: Q2 2026 in Review

Armistice Capital sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 118,289 shares — an estimated $8.42M sold.

Armistice Capital first reported a position in GEHC in Q3 2024 and held it in 7 quarters. The position peaked at $65M in Q4 2025. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Armistice Capital reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Armistice Capital sold 118,289 GE HealthCare shares in Q2 2026, an estimated $8.42M.
  • Armistice Capital first reported a position in GE HealthCare in Q3 2024 and held it in 7 quarters.
  • Armistice Capital's GE HealthCare position peaked at $65M in Q4 2025.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.